Manufacturing
Page 1 • 8 itemsGlobal pharma manufacturing insights: Track supply chain, CMC, regulatory compliance, and innovation trends impacting drug production. Stay ahead.
ROIS Expands to US Market as Global CDMO with FDA Approval for Injectable Drug Manufacturing
ROIS establishes US operations as global CDMO with FDA, EMA, and other major regulatory approvals for end-to-end injectable drug manufacturing services.
WuXi Biologics Chengdu Microbial Manufacturing Site Reaches Structural Completion, Targets 2026 GMP Production
WuXi Biologics announces structural completion of its Chengdu microbial manufacturing facility with key equipment arrival, targeting GMP production by end 2026.
Quasar Medical Opens New Thailand Manufacturing Facility to Expand MedTech Production Capacity
Quasar Medical inaugurates new Chonburi manufacturing facility in Thailand, boosting global production capacity for interventional medical devices.
Amcor Opens $35M Healthcare Packaging Facility in Malaysia to Strengthen Southeast Asia Medical Supply Chain
Amcor invests $35M in advanced healthcare packaging facility in Malaysia, bringing sterile medical packaging capabilities to Southeast Asia market.
WuXi Biologics Receives South Korea GMP Certification for Bispecific Antibody Manufacturing
WuXi Biologics secures South Korea MFDS GMP certification for three facilities, enabling commercial manufacturing of bispecific antibody therapeutics.
Andelyn Biosciences Partners with ENCell to Expand Gene Therapy Manufacturing in Asia-Pacific
Andelyn Biosciences and ENCell form strategic partnership to enhance global gene therapy manufacturing capabilities and expand access to treatments.
WuXi Biologics Achieves ISO 13485 Certification for Drug-Device Combination Products Manufacturing
WuXi Biologics becomes first in China to achieve ISO 13485:2016 certification with zero non-conformities for drug-device combination product development.
NMPA GMP Standards: Key Updates and Impact on Foreign Pharma Manufacturers
This article explores key updates to NMPA GMP standards and their significant implications for foreign pharmaceutical manufacturers in the Chinese market.